Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Neurology Physician in Clearwater, FL
NPI: 1306895149Primary Practice Location
MEASE DUNEDIN HOSPITAL
601 Main St, Dunedin, FL
Primary Employer
Clinical Neurosciences of Tampa Bay LLP
tampabayneurology.com
HQ Phone
Get M.D. Ajay's Phone Numberphone_androidMobile
Get M.D. Ajay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1997 - 2027
GA State Medical License
2000 - 2001
American Board of Psychiatry and Neurology
Neurology
USF Health Morsani College of Medicine
health.usf.edu
Medical School
Until 1996
University of South Florida Morsani
Internship • Internal Medicine
1996 - 1997
Emory School of Medicine
med.emory.edu
Fellowship • Vascular Neurology
2000 - 2001
Residency • Neurology
1997 - 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 401 | 567 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 146 | 146 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 111 | 111 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 103 | 121 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 68 | 74 |
A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.
Authors: David Hackney, Joshua Klein
Publication Date: 2011-01
Lead Sponsor: Bayer
Intervention / Treatment: DRUG: Placebo, DRUG: Asundexian (BAY2433334)
Lead Sponsor: University of Florida
Collaborators: Janssen Scientific Affairs, LLC, National Institute of Neurological Disorders and Stroke (NINDS), AstraZeneca, Medical University of South Carolina, University of Cincinnati
Intervention / Treatment: DRUG: Clopidogrel + Aspirin, OTHER: Risk Factor Management, DRUG: Ticagrelor + Aspirin, DRUG: Rivaroxaban + Aspirin
Lead Sponsor: Yale University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Intervention / Treatment: DRUG: Aspirin, DRUG: Apixaban
